Compound class:
Synthetic organic
|
|
No information available. |
Summary of Clinical Use ![]() |
ANT3310 in combination with meropenem has been advanced to Phase 1 first-in-human clinical evaluation in healthy subjects (NCT05905913). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT05905913 | FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects | Phase 1 Interventional | Antabio |